Adjuvant Treatment Based on MRD for EGFR Mutant NSCLC
Clinical trial NCT05536505 · RECRUITING
Trial details
- NCT number
- NCT05536505
- Sponsor
- Guangdong Association of Clinical Trials
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-09-13
- Primary completion
- 2025-10-01
- Enrollment
- 180
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.